BioSpace News Archive

Hyloris Pharmaceuticals SA, a specialty biopharma company committed to addressing unmet medical needs through reinventing existing medications, announces that it will host a conference call and audio webcast on Wednesday, 4 August 2021 at 3:00 pm CEST to present its half-year 2021 financial results and to provide a business update.

An ongoing strategic growth plan from Cytiva and Pall Corporation, part of the Danaher Corporation, will expand manufacturing capacity and services across geographies for global life sciences customers.

The growing prevalence of lifestyle disease and rising number of elderly population are some of the key factors stimulating growth of the global wearable skin patch market in the coming years.

The preventive medicine market is extrapolated to shine bright through the forecast period of 2018-2026 on the grounds of the rising awareness about the importance of early detection of diseases among a considerable chunk of the global populace.

The development of the healthcare industry and the introduction of new drugs and therapeutics are the key factors estimated to encourage the growth of the global PEGylated proteins market in the next few years.

The disease does not yet have a treatment. However, devices like NeuroAD have been approved for treatment in Europe, and Israel.

Fact.MR – A Market Research and Competitive Intelligence Provider: The global infrared thermometer market is expected to rise at an impressive rate owing to the surge in COVID-19 cases across the globe.

Samsung Biologics, the world’s leading contract development and manufacturing organization, announced strong financial results for the second quarter of fiscal 2021.

iOnctura SA, a clinical stage oncology company targeting core resistance and relapse mechanisms at the tumor-stroma-immune interface, announces the support of Innosuisse in a 2-year innovation project to explore the potential of iOnctura’s lead molecule, the PI3Kδ-inhibitor IOA-244, in the treatment of lymphoma.

Biodesix, Inc., a leading data-driven diagnostic solutions company with a focus in lung disease, announced that it will release financial results for the second quarter ended June 30, 2021 after the close of trading on Tuesday, August 10.